Beschreibung
Specific probiotic strains highlighted in the review for their demonstrated effects on metabolic parameters. Lactobacillus and Bifidobacterium species are mapped to their respective metabolic targets and clinical evidence levels.
Figure 15
DiagramSource Paper
Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives.Cite This Figure
![Figure 15: Specific probiotic strains highlighted in the review for their demonstrated effects on metabolic parameters. Lactobacillus and Bifidobacterium species are mapped to their respective metabolic targets and clinical evidence levels.]() > Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." *International journal of molecular sciences*, 2025. PMID: [40564947](https://pubmed.ncbi.nlm.nih.gov/40564947/)
<figure> <img src="" alt="Specific probiotic strains highlighted in the review for their demonstrated effects on metabolic parameters. Lactobacillus and Bifidobacterium species are mapped to their respective metabolic targets and clinical evidence levels." /> <figcaption>Figure 15. Specific probiotic strains highlighted in the review for their demonstrated effects on metabolic parameters. Lactobacillus and Bifidobacterium species are mapped to their respective metabolic targets and clinical evidence levels.<br> Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." <em>International journal of molecular sciences</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40564947/">40564947</a></figcaption> </figure>